Physician profile
Thomas Lim
NPI 1093770729
$374.39
in general payments reported to CMS, 2019-2025
8 companies · $25.37 in 2025
The $25.37 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.36 · 2020: $14.76 · 2023: $241 · 2025: $25.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $124.24 | 2023 | Nuzyra |
| Horizon Therapeutics Plc | $116.66 | 2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $38.56 | 2019-2020 | |
| Amgen INC. | $25.37 | 2025 | Krystexxa |
| Sandoz INC. | $21.82 | 2019 | |
| Acell, INC. | $21.62 | 2019 | |
| Medartis INC. | $14.66 | 2019 | |
| Merck Sharp & Dohme LLC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.